The thymus in seronegative myasthenia gravis patients |
| |
Authors: | N. Willcox Myriam Schluep M. A. Ritter J. Newsom-Davis |
| |
Affiliation: | (1) Department of Neurological Science, Royal Free Hospital School of Medicine, London, UK;(2) National Hospital for Nervous Diseases, London, UK;(3) Neurosciences Group, Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, OX3 9DU Headington, UK;(4) Department of Immunology, Royal Postgraduate Medical School, DuCane Road, London, UK;(5) Present address: Department de Neurologie, CHUV, CH-1011 Lausanne, Switzerland |
| |
Abstract: | Summary In 5–10% of all patients with typical generalised myasthenia gravis (MG), serum antibody to the acetylcholine receptor (AChR) is undetectable. To determine whether these represent a distinct subgroup, we have compared the thymuses of 14 seronegatives, 70 seropositives and 12 non-myasthenic controls. By quantitative immunohistology on coded sections, the 7 seronegative samples were clearly distinguishable from the controls by the pronounced lymph node-type T-cell areas in the medulla. While these closely resembled those in the seropositive cases, germinal centres were significantly sparser, and total in vitro IgG production was disproportionately low (per B cell) in the 12 cases tested. Furthermore, specific anti-AChR production was never detected in any of these cultures. The data support the view that the medullary T-cell areas are the most consistent abnormalitiy in the MG thymus (though it may not be primary), and they strongly imply that seronegative and seropositive MG are distinct entities. |
| |
Keywords: | Myasthenia gravis thymus Thymic hyperplasia Thymitis Seronegative myasthenia gravis Human lymphocyte cultures |
本文献已被 SpringerLink 等数据库收录! |
|